Abstract
The Japan Breast Cancer Research Group (JBCRG) was founded in 2002, in order to perform good quality multicenter studies, and related clinical trials in close relation with research institutions in other countries and regions, as well as in Japan.Currently (Jan. 2014), 315 doctors from 214 Institutes are registered as JBCRG members who are specialists from the breast cancer treating hospitals around Japan. JBCRG has performed a variety of studies, including primary pharmacotherapy, pharmacotherapy for recurrent breast cancer, clinical trials on postoperative pharmacotherapy, prediction of prognosis in hormone receptor positive breast cancer, and prediction of the effect of chemotherapeutic drugs. JBCRG has reported a number of outcomes to academic societies and journals, and has obtained good reputation. Also, JBCRG is a member of Breast International Group (BIG), which is an international breast cancer research group.In order to save as many breast cancer patients as possible, and to improve their QOL, we will develop new diagnostic methods and treatments, and prophylaxes for breast cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
